Longeveron LLC

Price & Volume

Stats

Open	$1.14
Previous Close	$1.16
Day Range	$1.07-$1.14
52W Range	$0.47-$1.83
Market Cap	$33.9M
Shares Short	2M

Financials

Revenue (12 Mos)	$1.1M
Revenue Growth (YoY)	-39.5%
Gross Profit (12 Mos)	$803,000
Diluted EPS	-$1.29

News

Yahoo Finance • 6 days ago

Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)

Yahoo Finance • 27 days ago

The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed

Yahoo Finance • 4 months ago

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy

Yahoo Finance • 4 months ago

Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum

About

CFO	Ms. Lisa A. Locklear M.B.A.
Address	Life Science & Technology Park, Miami, FL, United States, 33136
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	38